Riik: Holland
keel: inglise
Allikas: HMA (Heads of Medicines Agencies)
chlamydophila felis (chlamydia psittaci) 10 Pfu, feline calicivirus 10 Pfu, feline herpesvirus 10 Pfu, Feline Panleucopaenia (Infectious Enteritis) Virus 10 Pfu
Intervet Nederland B.V.
QI06AF01
Powder and solvent for suspension for injection
Feline panleucopenia virus / parvovirus vaccine + Feline rhinotracheitis virus vaccine + Feline calicivirus vaccine + Chlamydia
Cats Non Food
2011-03-30
SUMMARY OF PRODUCT CHARACTERISTICS Nobivac Forcat (NL/V/0114/001/R/001) – Renew al product literature (day 90) revised 300311 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Forcat (AT/DE: Nobivac RCP-Chlam) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1 ml: Lyophilisate: ACTIVE SUBSTANCES: live attenuated feline calicivirus, strain F9: 4.6 log 10 PFU 1 ; live attenuated feline herpes virus type 1, strain G2620A: 5.2 log 10 PFU 1 ; live attenuated feline panleucopenia virus, strain MW-1: 4.3 log 10 CCID 50 2 ; live attenuated _Chlamydophila felis_, strain Baker: 2.3 log 10 CCID 50 2 . 1 PFU: Plaque-Forming Units 2 CCID 50 : Cell Culture Infective Dosis 50% EXCIPIENTS: For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of cats: to reduce the clinical signs caused by infection with feline calicivirus and feline herpes virus type 1, to reduce the severity of the clinical signs caused by infection with _Chlamydophila felis_, to prevent the clinical signs, leucopenia and virus excretion caused by infection with feline panleucopenia virus. Onset of immunity: for FCV and FHV: 4 weeks; for FPLV and _C. felis_: 3 weeks. Duration of immunity for FCV, FHV, _C. felis_: 1 year, for FPLV: 3 years. 4.3 CONTRAINDICATIONS See section 4.7 Nobivac Forcat (NL/V/0114/001/R/001) – Renew al product li Lugege kogu dokumenti